Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2006-05-23
2006-05-23
Kemmerer, Elizabeth (Department: 1647)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069100, C435S320100, C435S325000, C435S252300, C536S023100, C536S023500, C530S350000
Reexamination Certificate
active
07049422
ABSTRACT:
TR7 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing TR7 polypeptides and polynucleotides in the design of protocols for the treatment of chronic and acute inflammation, arthritis, septicemia, autoimmune diseases (such as inflammatory bowel disease and psoriasis), transplant rejection, graft versus host disease, infection, stroke, ischemia, acute respiratory disease syndrome, restenosis, brain injury, AIDS, bone diseases, cancer (such as lymphoproliferative disorders), atherosclerosis, and Alzheimers disease, among others and diagnostic assays for such conditions.
REFERENCES:
patent: 5350836 (1994-09-01), Kopchick et al.
patent: 6358508 (2002-03-01), Ni et al.
patent: 6660839 (2003-12-01), Deen et al.
patent: 2002/0164684 (2002-11-01), Ni et al.
patent: 2002/0168359 (2002-11-01), Ni et al.
patent: WO 96/43095 (1996-10-01), None
Schmidt, et al, 2003, J. Exp. Med., 197(1): 51-62.
Curfs, et al, 1997, Clin. Microbiol. Rev., 10(4): 742-780.
Murdoch and Finn, 2000, Blood, 15(95): 3032-3043.
Allende, et al, 2001, Clin. Diagn. Lab. Immunol., 8(1): 133-137.
Bork, P. (1996), Go hunting in sequence database but watch out for the tarps. Trends Genetics, 12(10):425-427.
Pilbeam, et al. 1993, Bone. 14:717-720.
Bork, P. (1998), Powers and Pitfalls in Sequence Analysis: The 70% Hurdle, Genome Res., 10:398-400, esp. p. 400.
Doerks, T. (1998), Protein annotation: detective work for function prediction. Trends Genetics. 14(6):248-250.
Kwon et al., “A newly-identified member of the tumor necrosis factor receptor superfamily”, Journal of Allergy and Clinical Immunology, vol. 99 (1), pp. 5467 (1997). ABSTACT.
Accession # AA351536, Adams, 1997.
Accession # AA155873, Hillrer, 1996.
Accession # D59902, Fujiwara, 1995.
Accession # AA357321 Adams, 1997.
Accession # AA374471 Adams, 1995.
Accession # N49208 Hillrer, 1996.
Accession # H44577 Hillrer, 1995.
EST #2051015.
STN Search Print out of TNF-Receptor Related Products.
Skolnick, J. (2000), From genes to protein structure and function: novel applications of computational approaches in the genomic era., Trends in Biotech., 18(1):34-39, esp. p. 36.
Murdoch, et al. (2000) Blood, 95(10):3032-3043.
Vukicevic, S. et al., (1996) Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7) PNAS USA 93-9021-9026.
Massague, J. (1987) The TGF-B Family of Growth and Differentiation Factors. Cell 49:437-438.
Smith, T. et al., (1997) The challenges of genome sequence annotation or “The devil is in the details”, Nature Biotech. 15:1222-1223.
Brenner, S. (1999) Errors in genome annotation. Trends in Genetics 15(4):132-133.
Frommel et al., J. Mol, Eval 198, p, 233-57, vol. 21.
Bowie et al.,Science 247, 1990, p 1306.
Ngo et al., The Protein Folding Problem, Ed Mertz, 1994, p. 4337.
George et al. et al. Macro mol., Seq & Syn, 1988, p. 127-149.
ACCESSION # H44234.
ACCESSION # AA382042.
EST # 1502886.
EST # 843791.
Fujiwara et al., “Unpublished” Database EMBL, XP002072603, Entryname HS073E08B, Aug. 27, 1995. Abstract.
Copy of European Search Report.
Bork, P. (2000) Powers and Pitfalls in Sequence Analysis: The 70% Hurdle. Genome Research 10:398-400.
Deen Keith Charles
Hurle Mark R.
Tan Kong B.
Young Peter
Kemmerer Elizabeth
SmithKline Beecham Corporation
Wegert Sandra
LandOfFree
Tumor necrosis related receptor, TR7 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tumor necrosis related receptor, TR7, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tumor necrosis related receptor, TR7 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3547008